Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (ChiCTR2500114833) titled 'Validation of artificial intelligence-based digital therapies for dosage decision-making in diabetic insulin therapy' on Dec. 17, 2025.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: The First Affiliated Hospital of University of Science and Technology of China
Condition:
Type 2 diabetes
Intervention:
Digital Therapy Group:Following digital therapy system advice for short-term intensive insulin therapy
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: 2024-11-27
Target Sample Size: Digital Therapy Group:149;Conventional treatment group:149;
Countries of ...